Beverly Baker-Newsholme
Nurse Practitioner · Parker, CONPI 1649330218
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.7% of the total across 86 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by AbbVie at 31.8% of the total. Reporting peaked in 2024 at $1,059 and has fallen 66.0% since, to $360 in 2025. Among nurse practitioner clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 86 payments — averaging $21.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$597
- Pfizer$252
- SK Life Science, Inc.$212
- Lilly USA, LLC$206
- Vanda Pharmaceuticals Inc.$89
- Biogen$87
- plus $433 from 11 others
What the payments were for
- Food & beverage$1,70491%
- Education$1749%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 25 | $597 |
| Pfizer | 18 | $252 |
| SK Life Science, Inc. | 5 | $212 |
| Lilly USA, LLC | 12 | $206 |
| Vanda Pharmaceuticals Inc. | 3 | $89 |
| Biogen | 4 | $87 |
| Jazz Pharmaceuticals Inc. | 3 | $67 |
| Neurelis, Inc. | 2 | $59 |
| Lundbeck LLC | 2 | $55 |
| Harmony Biosciences LLC | 1 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Neurocrine Biosciences, Inc. | 2 | $42 |
| Acadia Pharmaceuticals Inc | 2 | $35 |
| Teva Pharmaceuticals USA, Inc. | 2 | $30 |
| Novartis | 1 | $24 |
| Scilex Pharmaceuticals Inc. | 1 | $20 |
| Amgen | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,878 in reported general payments places this provider in the 90th percentile of 1,384 nurse practitioner providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Emgality PenGalcanezumab-Gnlm | 16 | $20,423 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 11 | $2,158 |
| RizatriptanRizatriptan Benzoate | 25 | $424 |
| Donepezil Hcl | 46 | $353 |
| Prednisone | 14 | $33 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Parker
- Darla PearceParker$8K
- Deborah HinnenColorado Springs$388K
- Christina HansonLone Tree$381K
- Kara HartPueblo$142K
- Amy SidorskiAurora$97K
- Lori WenzGrand Junction$54K
- Lisa KeithColorado Springs$52K
- Victoria SegroEnglewood$29K
- Christina ProulxDenver$28K
- Jose Diaz LeoDenver$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.